Now showing items 1-1 of 1

    • In Silico Design Of Compounds As Sglt2 Inhibitors 

      Chakravorty, Kamaljyoti (Central University of Punjab, 2018)
      SGLT2 inhibitors (SGLT2i) are the current novel therapeutic approach expected to control the growing threat of type 2 diabetes mellitus (T2DM). With comparatively least reported side effects, SGLT2i (gliflozins) have been ...